Mar 26, 2024 3:55:25 PM | TCAP TriMetis: Pioneering Technology and AI Advancements in Healthcare

By leveraging AI, robotics, and cloud computing to streamline pathology, and cancer research workflows TriMetis ARCH Ecosystem improves efficiency and accuracy in biospecimen acquisition, analysis, and lab automation.

Leveraging Life Sciences Technology for Improved Patient Outcomes


In the realm of biotech and AI advancements, TriMetis Life Sciences stands as a beacon of innovation. With a suite of products and services that revolutionize pathology, histopathology, and cancer research workflows, TriMetis is not just a participant in the technological revolution - it's leading the charge. 

ARCH Ecosystem: Accelerating Research, Changing Healthcare 
The ARCH Ecosystem, a groundbreaking system by TriMetis, is a testament to the company's commitment to technological advancement. Harnessing the power of artificial intelligence, cloud computing, robotics, and automation, the ARCH Ecosystem is transforming pathology and research workflows.

The ecosystem offers AI-based quality control analyses, digital image asset management, and a comprehensive biomaterial inventory system. It's not just about making processes more efficient - it's about making them more accurate, too. The ARCH Ecosystem provides unparalleled quality control assessment of biospecimens, thanks to its combination of TriMetis Computer-Assisted Pathology (TCAP) AI quality control analysis and its live H&E digital image viewer.

TCAP: The New Path Forward 
TriMetis Computer-Assisted Pathology (TCAP) is an AI-based software that automates laboratory quality control processes rapidly and accurately. It's designed to replace tedious manual analysis and generate tissue quality metrics, thereby boosting lab productivity and driving revenue.

TCAP is integrated into the ARCH Marketplace and ARCH LabFlow platforms, offering AI-driven quality control analysis paired with user-friendly access for biospecimen acquisition, as well as inventory management, and automated laboratory workflows. It's a testament to TriMetis commitment to advancing cancer research through software solutions and cutting-edge AI technologies. 

ARCH Marketplace: Research Samplified 
The ARCH Marketplace, a notable achievement for TriMetis, represents the first comprehensive biospecimen marketplace of its kind. It streamlines the traditionally cumbersome process of acquiring biospecimens by offering a searchable platform. More than a marketplace, ARCH provides additional features such as AI analysis and lab-specific quality control. Its goal is to simplify and improve the acquisition and analysis of biospecimens for medical research and innovation. With on-demand AI analysis capabilities, users can conveniently upload tissue images, analyze them using TCAP AI, and access results that offer unparalleled utility and information.


For Buying Biospecimens: Streamlining Procurement Processes  
For Buyers, the ARCH Marketplace is a game-changer. Gone are the days of excel files, email chains, and returns. It allows buyers to view samples and their data before making a purchase, streamlining procurement processes with a cloud-based solution that brings both buyers and suppliers together.  

 

For Research: Enhancing Results, Expediting Discoveries
For Researchers, the ARCH Marketplace offers unparalleled access to a diverse range of high-quality, AI-analyzed biospecimens. This innovative platform streamlines the procurement process, ensuring reliable and regulatory-compliant samples. By leveraging AI, researchers benefit from enhanced data transparency and accuracy, significantly reducing the time and effort needed for sample validation. This accelerates research timelines and improves the reliability of scientific outcomes. Researchers can focus on innovation and discovery, supported by a robust and transparent biospecimen sourcing system.

For Managing Biospecimens: Setting New Standards in Biospecimen Management 
For Biospecimen Management, the ARCH Marketplace offers a range of technologies and services, including AI analysis on-demand, inventory and digital image management, and more. It's a platform that's built on Salesforce, allowing for the deployment of fully featured private instances.

For Supplying Biospecimens: Revolutionizing the Biospecimen Supply Chain
For Suppliers, the ARCH Marketplace offers a unique opportunity. It's not just about selling biospecimens - it's about being part of a platform that not only connects buyers and suppliers globally but displays inventories with digital images, backed by AI-powered assessment showcasing the biospecimen’s contents, including tumor percentage, nuclei count and more, ultimately setting new standards in biospecimen procurement and acquisition.

The ARCH Marketplace is not only another feather in TriMetis' cap. It's the first truly searchable, all-in-one biospecimen marketplace, designed to simplify the historically difficult and time-consuming process of acquiring biospecimens from end-to-end.  

ARCH LabFlow: The Laboratory Workflow Revolution
The ARCH LabFlow, featuring the TCAP quality control system, is designed to streamline the testing process and ensure unparalleled precision and efficiency in pathology groups and molecular profiling labs. It automates lab-specific quality control metrics, saving time and resources, and facilitates lab growth with automated tissue quality metrics at a fraction of the cost of hiring new staff. 

Robotics & Rules Engines: Efficiency Meets Automation
By leveraging artificial intelligence, robotics, cloud computing, and a rules engine ARCH LabFlow automates your laboratory workflows. Through the combination of TCAP AI with ISENET’S Galileo TMAtic Coring Robot, the assessment and coring of your tissues can be automated for downstream analysis. Taking it a step further, ARCH LabFlow features a rules engine in which you can set custom criteria tailored to your workflows for even further laboratory automation specific to your requirements.  

TriMetis Life Sciences is more than just a tech company – we’re pioneers in biotech, technological advancement, AI development, and innovation. With our suite of products and services, TriMetis is revolutionizing pathology, histopathology, and cancer research workflows, setting new standards in biospecimen procurement and acquisition, leading the charge in the technological revolution, and paving the way for the new path forward. 

Written By: Kaitlynn Clement